Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 2, 2022 - Biogen and Samsung Bioepis announced the launch of Byooviz (ranibizumab-nuna), a biosimilar to Genentech’s Lucentis® (ranibizumab).
Download PDF
Return to publications
